Curcumin and its nano-formulation: The kinetics of tissue distribution and blood-brain barrier penetration

International Journal of Pharmaceutics

Volumn 416, Issue 1, 2011, Pages 331-338

  Tsai, Yin Meng ^a   Chien, Chao Feng ^a   Lin, Lie Chwen ^a,b   Tsai, Tung Hu ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Blood brain barrier; Curcumin; Nanoparticles; Pharmacokinetics; PLGA

Indexed keywords

CURCUMIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; CONTROLLED STUDY; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG RETENTION; EMULSION; EVAPORATION; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; KIDNEY; LIVER; LUNG; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SPLEEN; TISSUE DISTRIBUTION;

ANIMALS; BLOOD-BRAIN BARRIER; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CURCUMIN; DRUG CARRIERS; DRUG COMPOUNDING; LACTIC ACID; MALE; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SURFACE PROPERTIES; TISSUE DISTRIBUTION;

EID: 80051788387     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.06.030     Document Type: Article

References (43)

1. W. Abdelwahed, G. Degobert, S. Stainmesse, and H. Fessi Freeze-drying of nanoparticles: formulation, process and storage considerations Adv. Drug. Deliv. Rev. 58 2006 1688 1713 (Pubitemid 44827432)
2. M.I. Alam, S. Beg, A. Samad, S. Baboota, K. Kohli, J. Ali, A. Ahuja, and M. Akbar Strategy for effective brain drug delivery Eur. J. Pharm. Sci. 40 2010 385 403
3. H. Ammon, and M.A. Wahl Pharmacology of Curcuma longa Planta Med. 57 1991 1 7
4. P. Anand, A.B. Kunnumakkara, R.A. Newman, and B.B. Aggarwal Bioavailability of curcumin: problems and promises Mol. Pharm. 4 2007 807 818
5. P. Anand, H.B. Nair, B. Sung, A.B. Kunnumakkara, V.R. Yadav, R.R. Tekmal, and B.B. Aggarwal Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo Biochem. Pharmacol. 79 2010 330 338
6. D.M. Andrade Genetic basis in epilepsies caused by malformations of cortical development and in those with structurally normal brain Hum. Genet. 126 2009 173 193
7. C.F. Chien, Y.T. Wu, W.C. Lee, L.C. Lin, and T.H. Tsai Herb-drug interaction of Andrographis paniculata extract and andrographolide on the pharmacokinetics of theophylline in rats Chem. Biol. Interact. 184 2010 458 465
8. C.C. DeMerlis, and D.R. Schoneker Review of the oral toxicity of polyvinyl alcohol (PVA) Food Chem. Toxicol. 41 2003 319 326 (Pubitemid 36015770)
9. N. Faisant, J. Siepmann, and J.P. Benoit PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release Eur. J. Pharm. Sci. 15 2002 355 366 (Pubitemid 34436923)
10. M. Garcia-Alloza, L.A. Borrelli, A. Rozkalne, B.T. Hyman, and B.J. Bacskai Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model J. Neurochem. 102 2007 1095 1104 (Pubitemid 47174225)
11. M. Gururajan, T. Dasu, S. Shahidain, C.D. Jennings, D.A. Robertson, V.M. Rangnekar, and S. Bondada Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth J. Immunol. 178 2007 111 121 (Pubitemid 46033592)
12. C. He, Y. Hu, L. Yin, C. Tang, and C. Yin Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles Biomaterials 31 2010 3657 3666
13. T. Higuchi Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices J. Pharm. Sci. 52 1963 1145 1149
14. J. Jaiswal, S.K. Gupta, and J. Kreuter Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process J. Control. Release 96 2004 169 178 (Pubitemid 38438499)
15. T.H. Kim, H.H. Jiang, Y.S. Youn, C.W. Park, K.K. Tak, S. Lee, H. Kim, S. Jon, X. Chen, and K.C. Lee Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity Int. J. Pharm. 403 2011 285 291
16. D.P. Lankveld, A.G. Oomen, P. Krystek, A. Neigh, A. Troost-de Jong, C.W. Noorlander, J.C. Van Eijkeren, R.E. Geertsma, and W.H. De Jong The kinetics of the tissue distribution of silver nanoparticles of different sizes Biomaterials 2010 PMID: 20684985
17. S.D. Li, and L. Huang Pharmacokinetics and biodistribution of nanoparticles Mol. Pharm. 5 2008 496 504
18. H.F. Liang, T.F. Yang, C.T. Huang, M.C. Chen, and H.W. Sung Preparation of nanoparticles composed of poly(gamma-glutamic acid)-poly(lactide) block copolymers and evaluation of their uptake by HepG2 cells J. Control. Release 105 2005 213 225
19. Z. Ma, A. Shayeganpour, D.R. Brocks, A. Lavasanifar, and J. Samuel High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin Biomed. Chromatogr. 21 2007 546 552 (Pubitemid 46736190)
20. C. Mancuso, R. Siciliano, and E. Barone Curcumin and Alzheimer disease: this marriage is not to be performed J. Biol. Chem. 285 2011 28472 28480
21. R. Manikandan, R. Thiagarajan, S. Beulaja, G. Sudhandiran, and M. Arumugam Curcumin protects against hepatic and renal injuries mediated by inducible nitric oxide synthase during selenium-induced toxicity in Wistar rats Microsc. Res. Tech. 73 2010 631 637
22. M.W. Marlatt, and P.J. Lucassen Neurogenesis and Alzheimer's disease: biology and pathophysiology in mice and men Curr. Alzheimer Res. 7 2010 113 125
23. E. Mastrobattista, G.A. Koning, and G. Storm Immunoliposomes for the targeted delivery of antitumor drugs Adv. Drug Deliv. Rev. 40 1999 103 127 (Pubitemid 29486607)
24. S.J. Moghaddam, P. Barta, S.G. Mirabolfathinejad, Z. Ammar-Aouchiche, N.T. Garza, T.T. Vo, R.A. Newman, B.B. Aggarwal, C.M. Evans, M.J. Tuvim, R. Lotan, and B.F. Dickey Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice Carcinogenesis 30 2009 1949 1956
25. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 2001 283 318 (Pubitemid 32476118)
26. C. Mohanty, and S.K. Sahoo The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation Biomaterials 31 2010 6597 6611
27. R.H. Müller Colloidal Carriers for Controlled Drug Delivery and Targeting 1991 CRC Press Boca Raton pp. 45-56
28. R.B. Mythri, B. Jagatha, N. Pradhan, J. Andersen, and M.M. Bharath Mitochondrial complex I inhibition in Parkinson's disease: how can curcumin protect mitochondria? Antioxid. Redox. Signal. 9 2007 399 408 (Pubitemid 46145986)
29. T.G. Park Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition Biomaterials 16 1995 1123 1130
30. S. Purkayastha, A. Berliner, S.S. Fernando, B. Ranasinghe, I. Ray, H. Tariq, and P. Banerjee Curcumin blocks brain tumor formation Brain Res. 1266 2009 130 138
31. M. Sarter, and V. Parikh Choline transporters, cholinergic transmission and cognition Nat. Rev. Neurosci. 6 2005 48 56 (Pubitemid 40052138)
32. S. Schmidt, D. Gonzalez, and H. Derendorf Significance of protein binding in pharmacokinetics and pharmacodynamics J. Pharm. Sci. 99 2010 1107 1122
33. P. Sethi, A. Jyoti, E. Hussain, and D. Sharma Curcumin attenuates aluminium-induced functional neurotoxicity in rats Pharmacol. Biochem. Behav. 93 2009 31 39
34. J. Shaikh, D.D. Ankola, V. Beniwal, D. Singh, and M.N. Kumar Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer Eur. J. Pharm. Sci. 37 2009 223 230
35. A. Shehzad, F. Wahid, and Y.S. Lee Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials Arch. Pharm. 343 2010 489 499
36. Y. Sumanont, Y. Murakami, M. Tohda, O. Vajragupta, H. Watanabe, and K. Matsumoto Effects of manganese complexes of curcumin and diacetylcurcumin on kainic acid-induced neurotoxic responses in the rat hippocampus Biol. Pharm. Bull. 30 2007 1732 1739 (Pubitemid 47403254)
37. Y.M. Tsai, W.C. Jan, C.F. Chien, W.C. Lee, L.C. Lin, and T.H. Tsai Optimised nano-formulation on the bioavailability of hydrophobic polyphenol, curcumin, in freely-moving rats Food Chem. 2011 10.1016/j.foodchem.2011.01.059
38. M.S. Wang, S. Boddapati, S. Emadi, and M.R. Sierks Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model BMC Neurosci. 11 2010 57 67
39. S.J. Wu, K.W. Tam, Y.H. Tsai, C.C. Chang, and J.C. Chao Curcumin and saikosaponin an inhibit chemical-induced liver inflammation and fibrosis in rats Am. J. Chin. Med. 38 2010 99 111
40. M.M. Yallapu, B.K. Gupta, M. Jaggi, and S.C. Chauhan Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells J. Colloid Interface Sci. 2010 PMID: 20627257
41. K.Y. Yang, L.C. Lin, T.Y. Tseng, S.C. Wang, and T.H. Tsai Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 853 2007 183 189
42. B.S. Zolnik, and D.J. Burgess Effect of acidic pH on PLGA microsphere degradation and release J. Control. Release 122 2007 338 434
43. B.S. Zolnik, P.E. Leary, and D.J. Burgess Elevated temperature accelerated release testing of PLGA microspheres J. Control. Release 112 2006 293 300 (Pubitemid 43737147)